Key result
Left ventricular assist device (HeartMate 3) implantation resulted in successful hospital discharge and survival in 2 of 3 patients with end-stage Duchenne dilated cardiomyopathy.
Why the study?
Specific guidelines for advanced heart failure in Duchenne muscular dystrophy are lacking because of limited life expectancy, and long-term LVAD outcomes in Duchenne dilated cardiomyopathy had not been reported in the Asia-Pacific region.
Does HeartMate 3 left ventricular assist device implantation improve survival and clinical outcomes in patients with end-stage Duchenne muscular dystrophy-related dilated cardiomyopathy and advanced heart failure?
Case Report (n=3)
No
Does HeartMate 3 left ventricular assist device implantation improve survival and clinical outcomes in patients with end-stage Duchenne muscular dystrophy-related dilated cardiomyopathy and advanced heart failure?
This first reported case series in the Asia-Pacific region demonstrates that HeartMate 3 LVAD implantation is a feasible life-prolonging option for carefully selected patients with advanced heart failure due to Duchenne muscular dystrophy cardiomyopathy, particularly when intervened prior to complete ventilator dependency.
Answers are grounded in this paper and cite their sources.
May support LVAD use in selected Duchenne DCM patients; leaves open prospective validation before wider adoption.
A 19-year-old male with genetically confirmed DMD was transferred to the Adult Cardiology Department.The patient was non-ambulatory and intermittently dependent on noninvasive ventilation (NIV) at night.The left ventricular ejection fraction (LVEF) was 42% without heart failure (HF) symptoms.Three months later, he visited the emergency department (ED) with ST-segment elevation myocardial infarction and concomitant atrial fibrillation.Thrombectomy was successfully performed, and the ST elevation subsided with sinus conversion.Guidelinedirected medical therapy (GDMT) for HF was continued for a year.On November 5, 2020, the patient visited the ED with severe dyspnea.The patient was discharged after a short-term dobutamine treatment.However, he became dependent on dobutamine after 2 more HF hospitalizations.Heart transplantation or LVAD were considered; however, there was no preceding case that is similar reported in the Asia-Pacific region.A multi-disciplinary team (MDT) discussed technical issues associated with severe scoliosis (Figure 1A) and potential ethical problems.
No takes yet. Share an insight, caveat, or question.
Lee et al. (2025) conducted a case report in Duchenne muscular dystrophy-related dilated cardiomyopathy (DMD-DCM) with advanced heart failure (n=3). Left ventricular assist device implantation (HeartMate 3) was evaluated on Postoperative survival and discharge. Left ventricular assist device (HeartMate 3) implantation resulted in successful hospital discharge and survival in 2 of 3 patients with end-stage Duchenne dilated cardiomyopathy.
Synapse has enriched 10 related papers. Consider them for comparative context: